Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GXO | BROS |
|---|---|---|
| Price | $45.99 | $38.23 |
| Change today | ▼ 1.22% | ▼ 1.14% |
| Market cap | $5.27B | $5.27B |
| Return, 3 months | -11.3% | -42.3% |
| Return, year to date | -12.6% | -37.6% |
| Return, 1 year | -17.0% | -22.0% |
| P/E (TTM) | 40.7 | 53.1 |
| P/B | 1.8 | 6.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 49 | 26 |
| 30-day volatility | 27.4% | 33.8% |
| Max drawdown, 1 year | -32.7% | -48.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
